James Huang, Director, 10% Owner at WINDTREE THERAPEUTICS INC /DE/ (WINT), bought 5,000 shares at $3.81 ($19K) on 2019-12-30, disclosed to the SEC on 2019-12-31.
Open-market purchase of $19k WINT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.73 | 4,091 | $15K | 81.5% |
| 2 | $3.81 | 909 | $3K | 18.5% |
| Total | $3.74 avg | 5,000 | $19K | 100% |
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |